Transcription patterning of uncoupled proliferation and differentiation in myelodysplastic bone marrow with erythroid-focused arrays

Blood

Volumn 98, Issue 6, 2001, Pages 1914-1921

  Terry Lee, Y ^a,b,c   Miller, Lance D ^a,b,c   Gubin, Alexander N ^a,b,c   Makhlouf, Fairouz ^a,b,c   Wojda, Urszula ^a,b,c   John Barrett, A ^a,b,c   Liu, Edison T ^a,b,c   Miller, Jeffery L ^a,b,c,d  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; CLINICAL ARTICLE; ERYTHROID CELL; ERYTHROLEUKEMIA; FEMALE; GENE ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYBRIDIZATION; MALE; MOLECULAR CLONING; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REFRACTORY ANEMIA; SIDEROBLASTIC ANEMIA;

EID: 0035885971     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.6.1914     Document Type: Article

References (26)

1. Gardais J. Dyshaemopoiesis in adults: a practical classification for diagnosis and management. Leuk Res. 2000;8:641-651.
2. Lotem J, Sachs L. Mechanisms that uncouple growth and differentiation in myeloid leukemia cells: restoration of requirement for normal growth-inducing protein without restoring induction of differentiation-inducing protein. Proc Natl Acad Sci U S A. 1982;79:4347-4351.
3. Raza A, Gezer S, Mundle S, et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood. 1995;86:268-276.
4. Bishop JM. Molecular themes in oncogenesis. Cell. 1991;64:235-248.
5. Barrett J, Saunthararajah Y, Molldrem J. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? Semin Hematol. 2000;37:15-29.
6. Bain BJ. The relationship between the myelodysplastic syndromes and the myeloproliferative disorders. Leuk Lymphoma. 1999;34:443-449.
7. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189-199.
8. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079-2088.
9. Bos JL. ras oncogenes in human cancer. Cancer Res. 1989;49:4682-4689.
10. Adamson DJ, Dawson AA, Bennett B, King DJ, Haites NE. p53 mutation in the myelodysplastic syndromes. Br J Haematol. 1995;89:61-66.
11. Pedersen B. 5q(-) survival: importance of gender and deleted 5q bands and survival analysis based on 324 published cases. Leuk Lymphoma. 1998;31:325-334.
12. Gubin AN, Njoroge JN, Bouffard GG, Miller JL. Gene expression in proliferating human erythroid cells. Genomics. 1999;15:168-177.
13. Miller JM, Njoroge JN, Gubin AN, Rodgers GP. Prospective identification of erythroid elements in cultured peripheral blood. Exp Hematol. 1999;27:624-629.
14. Stamatoyannopoulos G, Nienhuis AW. Hemoglobin switching. In: Stamatoyannopoulos G, et al, eds. The Molecular Basis of Blood Diseases. Philadelphia, PA: WB Saunders; 1994:107-154.
15. Alizadeh A, Eisen M, Botstein D, Brown PO, Staudt LM. Probing lymphocyte biology by genomic-scale gene expression analysis. J Clin Immunol. 1998;18:373-379.
16. Liu X, Rapp N, Deans R, Cheng L. Molecular cloning and chromosomal mapping of a candidate cytokine gene selectively expressed in human CD34+ cells. Genomics. 2000;65:283-292.
17. Phillips RL, Ernst RE, Brunk B, et al. The genetic program of hematopoietic stem cells. Science. 2000;288:1635-1640.
18. Hashimoto SI, Suzuki T, Nagai S, et al. Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood. 2000;96:2206-2214.
19. Schmidt M, NazarovV, Stevens L, Watson R, Wolff L. Regulation of the resident chromosomal copy of c-myc by c-Myb is involved in myeloid leukemogenesis. Mol Cell Biol. 2000;20:1970-1981.
20. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503-511.
21. Hegde P, Qi R, Abernathy K, et al. A concise guide to cDNA microarray analysis. Biotechniques. 2000;29:548-560.
22. Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood. 1995;85:2315-2320.
23. Niitsu N, Okabe-Kado J, Nakayama M, et al. Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia. Blood. 2000;96:1080-1086.
24. Baines P, Bowen D, Jacobs A. Clonal growth of haemopoietic progenitor cells from myelodysplastic marrow in response to recombinant haemopoietins. Leuk Res. 1990;14:247-253.
25. Yoshida Y, Mufti GJ. Apoptosis and its significance in MDS: controversies revisited. Leuk Res. 1999;23:777-785.
26. Kouides PA, Bennett JM. Morphology and classification of the myelodysplastic syndromes and their pathologic variants. Semin Hematol. 1996;33:95-110.